152 related articles for article (PubMed ID: 1581534)
21. Examination of the structure-toxicity relationships of L-cysteine-S-conjugates of halogenated alkenes and their corresponding mercapturic acids in rat renal tissue slices.
Stijntjes GJ; Commandeur JN; te Koppele JM; McGuinness S; Gandolfi AJ; Vermeulen NP
Toxicology; 1993 Mar; 79(1):67-79. PubMed ID: 8475500
[TBL] [Abstract][Full Text] [Related]
22. Stereochemistry of the microsomal glutathione S-transferase catalyzed addition of glutathione to chlorotrifluoroethene.
Hargus SJ; Fitzsimmons ME; Aniya Y; Anders MW
Biochemistry; 1991 Jan; 30(3):717-21. PubMed ID: 1988059
[TBL] [Abstract][Full Text] [Related]
23. Structure-mutagenicity and structure-cytotoxicity studies on bromine-containing cysteine S-conjugates and related compounds.
Finkelstein MB; Vamvakas S; Bittner D; Anders MW
Chem Res Toxicol; 1994; 7(2):157-63. PubMed ID: 8199303
[TBL] [Abstract][Full Text] [Related]
24. A mechanism of haloalkene-induced renal carcinogenesis.
Dekant W; Vamvakas S; Koob M; Köchling A; Kanhai W; Müller D; Henschler D
Environ Health Perspect; 1990 Aug; 88():107-10. PubMed ID: 2272303
[TBL] [Abstract][Full Text] [Related]
25. The effect of haloalkene cysteine conjugates on rat renal glutathione reductase and lipoyl dehydrogenase activities.
Lock EA; Schnellmann RG
Toxicol Appl Pharmacol; 1990 Jun; 104(1):180-90. PubMed ID: 2360207
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation of L-cysteine S-conjugates and N-acetyl-L-cysteine S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human kidney in vitro: interindividual variability in N-acetylation, N-deacetylation, and beta-lyase-catalyzed metabolism.
Gul Altuntas T; Kharasch ED
Drug Metab Dispos; 2002 Feb; 30(2):148-54. PubMed ID: 11792683
[TBL] [Abstract][Full Text] [Related]
27. L-alanine-glyoxylate aminotransferase II of rat kidney and liver mitochondria possesses cysteine S-conjugate beta-lyase activity: a contributing factor to the nephrotoxicity/hepatotoxicity of halogenated alkenes?
Cooper AJ; Krasnikov BF; Okuno E; Jeitner TM
Biochem J; 2003 Nov; 376(Pt 1):169-78. PubMed ID: 12859250
[TBL] [Abstract][Full Text] [Related]
28. Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.
Harris JW; Pohl LR; Martin JL; Anders MW
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1407-10. PubMed ID: 1996342
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine to hydrogen sulfide and the role of hydrogen sulfide in S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine-induced mitochondrial toxicity.
Banki K; Elfarra AA; Lash LH; Anders MW
Biochem Biophys Res Commun; 1986 Jul; 138(2):707-13. PubMed ID: 3741429
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of L-cysteine S-conjugates and N-(trideuteroacetyl)-L-cysteine S-conjugates of four fluoroethylenes in the rat. Role of balance of deacetylation and acetylation in relation to the nephrotoxicity of mercapturic acids.
Commandeur JN; Stijntjes GJ; Wijngaard J; Vermeulen NP
Biochem Pharmacol; 1991 Jun; 42(1):31-8. PubMed ID: 2069595
[TBL] [Abstract][Full Text] [Related]
31. Evidence for metabolism of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product, by cysteine conjugate beta-lyase.
Spracklin DK; Kharasch ED
Chem Res Toxicol; 1996 Jun; 9(4):696-702. PubMed ID: 8831812
[TBL] [Abstract][Full Text] [Related]
32. Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene.
Finkelstein MB; Baggs RB; Anders MW
J Pharmacol Exp Ther; 1992 Jun; 261(3):1248-52. PubMed ID: 1602387
[TBL] [Abstract][Full Text] [Related]
33. Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells.
McGoldrick TA; Lock EA; Rodilla V; Hawksworth GM
Arch Toxicol; 2003 Jul; 77(7):365-70. PubMed ID: 12700887
[TBL] [Abstract][Full Text] [Related]
34. Bioactivation mechanism of cytotoxic homocysteine S-conjugates.
Lash LH; Elfarra AA; Rakiewicz-Nemeth D; Anders MW
Arch Biochem Biophys; 1990 Feb; 276(2):322-30. PubMed ID: 2154944
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation.
Pähler A; Parker J; Dekant W
Toxicol Sci; 1999 Mar; 48(1):5-13. PubMed ID: 10330678
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial bioactivation of cysteine S-conjugates and 4-thiaalkanoates: implications for mitochondrial dysfunction and mitochondrial diseases.
Anders MW
Biochim Biophys Acta; 1995 May; 1271(1):51-7. PubMed ID: 7599225
[TBL] [Abstract][Full Text] [Related]
37. Nephrotoxicity of the glutathione and cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3, 3-pentafluoro-1-propene (Compound A) in male Fischer 344 rats.
Iyer RA; Baggs RB; Anders MW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1544-51. PubMed ID: 9400032
[TBL] [Abstract][Full Text] [Related]
38. Toxic, halogenated cysteine S-conjugates and targeting of mitochondrial enzymes of energy metabolism.
Cooper AJ; Bruschi SA; Anders MW
Biochem Pharmacol; 2002 Aug; 64(4):553-64. PubMed ID: 12167474
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation, excretion and nephrotoxicity of haloalkene-derived cysteine S-conjugates.
Birner G; Bernauer U; Werner M; Dekant W
Arch Toxicol; 1997; 72(1):1-8. PubMed ID: 9458184
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of tetrachloroethene in rats: identification of N epsilon-(dichloroacetyl)-L-lysine and N epsilon-(trichloroacetyl)-L-lysine as protein adducts.
Birner G; Richling C; Henschler D; Anders MW; Dekant W
Chem Res Toxicol; 1994; 7(6):724-32. PubMed ID: 7696525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
